Women's Cancers Track
Ovarian Cancer:
New Insights into Biology and Treatment
Ursula A. Matulonis, MD
HER2 Positive and Triple-Negative Breast Cancers: Making Individualized Treatment Selections in First and Later Line Settings
Eric P. Winer, MD
ER Positive Breast Cancers:
Impact of Recent Clinical Trial Results on Therapeutic Decision-Making
Harold J. Burstein, MD, PhD
Panel Discussion
All Supportive Care and Women's Cancers Track Faculty
Supportive Care Track
Supportive and Palliative Care:
Managing Symptoms and Improving Patient Outcomes
Janet L. Abrahm, MD
Identifying and Meeting the Medical and Psychological Needs of Cancer Survivors
Ann H. Partridge, MD, MPH
Genitourinary Cancers Track
Prostate Cancer:
Evidence-Based Treatment Selection for Advanced and Metastatic Disease
Philip W. Kantoff, MD / Mark M. Pomerantz, MD
Bladder and Renal Cancers:
Current Guideline-Based Management and Emerging Treatment Targets
Robert Dreicer, MD
Head, Neck and Lung Cancers Track
Head and Neck and Thyroid Cancers:
Incorporating New Therapies into Current Treatment Algorithms
Robert I. Haddad, MD
Non-Small Cell and Small Cell Lung Cancer:
Patient Selection for Immune-Based, Targeted, and Chemotherapeutic Treatment Options
Bruce E. Johnson, MD
|
Melanoma Cancer Track
Melanoma:
New Therapies for Advanced and Metastatic Disease and Recent Developments in Adjuvant Treatment
F. Steven Hodi Jr., MD / Antoni Ribas, MD / Jedd D. Wolchok, MD, PhD
Panel Discussion
All Head, Neck and Lung Cancers and Melanoma Cancer Track Faculty
Sarcoma Track
GIST and Soft Tissue Sarcomas:
Applying Recent Clinical Advances in Systemic Therapy in the Adjuvant and Metastatic Settings
George D. Demetri, MD
Gastrointestinal Cancer Track
Esophagogastic and Pancreatic Cancers:
Evidence-Based Use of Systemic Therapies in the Adjuvant and Metastatic Settings
Peter C. Enzinger, MD
Hereditary Gastrointestinal Cancers::
Advances in Genetics and Current Management
Sapna Syngal, MD, MPH / Matthew B. Yurgelun, MD
Role of Diet and Lifestyle in the Primary and Secondary Prevention of Gastrointestinal Cancers
Charles S. Fuchs, MD, MPH / Kimmie Ng, MD, MPH
Colorectal Cancer:
Selecting Systemic Therapies in the Adjuvant and Metastatic Settings based on Patient and Disease Characteristics
Robert J. Mayer, MD
Panel Discussion
All Gastrointestinal Cancers Track Faculty
Hematologic Malignancies Track
Non-Hodgkin and Hodgkin Lymphoma:
Using Patient and Disease Characteristics as a Guide to Treatment Selection
Arnold S. Freedman, MD
Myeloid Malignancies:
Current and Emerging Treatment Approaches in First and Later Line Settings
Daniel J. DeAngelo, MD, PhD / Richard M. Stone, MD
Myeloproliferative Neoplasms:
Individualized Treatment Based on Risk Stratification
Ayalew Tefferi, MD
Multiple Myeloma:
Optimal Selection and Sequencing of Systemic Therapies
Kenneth C. Anderson, MD
Chronic Lymphocytic Leukemia:
Incorporating Expanded Treatment Options into Current Management Paradigms
John C. Byrd, MD
Management of Thrombosis and Hypercoaguable Conditions in the Cancer Patient
Jean M. Connors, MD
Panel Discussion
All Hematologic Malignancies Track Faculty
|